← FDA Drug Approvals (Drugs@FDA)

CRYSVITA

BLA · Biologics License Application · Sponsor: KYOWA KIRIN · Approved 2018-04-17

Drug application

FDA Application #

BLA761068

Application type

Biologics License Application

Brand name

CRYSVITA

Generic name

BUROSUMAB

Active ingredients

BUROSUMAB-TWZA

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

KYOWA KIRIN

Manufacturer

Kyowa Kirin, Inc.

First approval

2018-04-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown